NCT06665438 Dexmedetomidine and Bupivacaine Intra-articular for Postoperative Analgesia After Knee Arthroscopic Surgery
| NCT ID | NCT06665438 |
| Status | Recruiting |
| Phase | Phase 3 |
| Sponsor | Al-Azhar University |
| Condition | Post Operative Analgesia |
| Study Type | INTERVENTIONAL |
| Enrollment | 75 participants |
| Start Date | 2024-12-01 |
| Primary Completion | 2025-04 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
Phase 3 trials are large pivotal studies comparing the treatment to current standard of care or placebo. Your participation directly contributes to the evidence needed for regulatory approval.
This trial targets 75 participants in total. It began in 2024-12-01 with a primary completion date of 2025-04.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study to compare the analgesic effects of intraarticular dexmedetomidine added to bupivacaine with those of bupivacaine alone after knee arthroscopy
Eligibility Criteria
Inclusion Criteria: * ASA I-II patients * Either sex * Aged 18-65 years * Candidates for anterior cruciate ligament (ACL) reconstruction by knee arthroscopy * Exclusion Criteria: * the patients with kidney failure, liver failure, valvular and ischemic heart disease , high blood pressure, diabetes, history of infection and malignancy. * history of coagulation diseases, and history of drug allergies to used drugs. * those who consumed NSAIDs and analgesics 24 h before surgery were excluded from the study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06665438 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Post Operative Analgesia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
What phase is the NCT06665438 trial and what does that mean for participants?
Phase 3 trials are large-scale studies comparing the new treatment to existing standards of care or a placebo. They provide the evidence needed for regulatory approval. This trial targets 75 participants.
Is NCT06665438 currently recruiting?
Yes, NCT06665438 is actively recruiting participants. Contact the research team at mohamedali.226@azhar.edu.eg for enrollment information.
Where is the NCT06665438 trial being conducted?
This trial is being conducted at Asyut, Egypt, Asyut, Egypt.
Who is sponsoring the NCT06665438 clinical trial?
NCT06665438 is sponsored by Al-Azhar University. The trial plans to enroll 75 participants.